Search Results - "Marciani, Dante"

Refine Results
  1. 1

    Elucidating the Mechanisms of Action of Saponin-Derived Adjuvants by Marciani, Dante J.

    “…Numerous triterpenoid saponins are adjuvants that modify the activities of T cells and antigen-presenting cells, like dendritic cells (DCs). Saponins can…”
    Get full text
    Journal Article
  2. 2

    Effects of N-acylation on the immune adjuvanticity of analogs of the Quillaja saponins derivative GPI-0100 by Marciani, Dante J.

    Published in Vaccine (29-07-2022)
    “…•Lipophilic alkyl chains alter Q. saponins’ conformation and associative properties.•Q. saponins’ micellar properties may affect the availability of certain…”
    Get full text
    Journal Article
  3. 3

    A retrospective analysis of the Alzheimer's disease vaccine progress – The critical need for new development strategies by Marciani, Dante J.

    Published in Journal of neurochemistry (01-06-2016)
    “…The promising results obtained with aducanumab and solanezumab against Alzheimer's disease (AD) strengthen the vaccine approach to prevent AD, despite of the…”
    Get full text
    Journal Article
  4. 4

    Alzheimer's disease vaccine development: A new strategy focusing on immune modulation by Marciani, Dante J

    Published in Journal of neuroimmunology (15-10-2015)
    “…Abstract Despite significant advances in the development of Alzheimer's disease (AD) vaccines effective in animal models, these prototypes have been clinically…”
    Get full text
    Journal Article
  5. 5

    New Th2 adjuvants for preventive and active immunotherapy of neurodegenerative proteinopathies by Marciani, Dante J.

    Published in Drug discovery today (01-07-2014)
    “…•Vaccine therapy of neurodegenerative proteopathies solely requires Th2 immunity.•Explaining the paradox of the AN-1792 Alzheimer's disease vaccine…”
    Get full text
    Journal Article
  6. 6

    Is fucose the answer to the immunomodulatory paradox of Quillaja saponins? by Marciani, Dante J.

    Published in International immunopharmacology (01-12-2015)
    “…Quillaja saponins, e.g. QS-21, are immunomodulating aldehyde-carrying triterpene glycosides, which depending on the acylation state of their single fucosyl…”
    Get full text
    Journal Article
  7. 7

    Rejecting the Alzheimer's disease vaccine development for the wrong reasons by Marciani, Dante J.

    Published in Drug discovery today (01-04-2017)
    “…•Tested Alzheimer vaccines were more suited for transgenic mouse models than humans.•Immunogen must have the conformational epitope found in toxic oligomeric…”
    Get full text
    Journal Article
  8. 8

    Effects of immunomodulators on the response induced by vaccines against autoimmune diseases by Marciani, Dante J.

    Published in Autoimmunity (Chur, Switzerland) (03-10-2017)
    “…A promising treatment for T-cell-mediated autoimmune diseases is the induction of immune tolerance by modulating the immune response against self-antigens, an…”
    Get full text
    Journal Article
  9. 9

    Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity by Marciani, Dante J.

    Published in Drug Discovery Today (15-10-2003)
    “…Inactivated vaccines require adjuvants to stimulate an immune response. The choice of adjuvant or immune enhancer determines whether the immune response is…”
    Get full text
    Book Review Journal Article
  10. 10

    Facing Alzheimer’s disease in the developing countries by Marciani, Dante J.

    Published in Revista de neuro-psiquiatría (28-06-2017)
    “…Aunque el incremento de casos de enfermedad de Alzheimer (EA) en los países desarrollados será limitado, en los países en desarrollo de América Latina, Asia y…”
    Get full text
    Journal Article
  11. 11

    Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100 by Marciani, Dante J, Reynolds, Robert C, Pathak, Ashish K, Finley-Woodman, Kyra, May, Richard D

    Published in Vaccine (08-09-2003)
    “…Unfractionated GPI-0100 (UFGPI-0100) containing semi-synthetic derivatives of deacylated Quillaja saponins (DS saponins) modified at the glucuronic acid…”
    Get full text
    Journal Article
  12. 12

    Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2 by Quenelle, Debra C., Collins, Deborah J., Marciani, Dante J., Kern, Earl R.

    Published in Vaccine (06-03-2006)
    “…These studies were performed to determine the effects of GPI-0100, a semi synthetic Quillaja Saponin analog, formulated with herpes simplex virus type-1…”
    Get full text
    Journal Article
  13. 13

    Effect of an immune enhancer, GPI-0100, on vaccination with live attenuated herpes simplex virus (HSV) type 2 or glycoprotein D on genital HSV-2 infections of guinea pigs by Quenelle, Debra C., Collins, Deborah J., Rice, Terri L., Prichard, Mark N., Marciani, Dante J., Kern, Earl R.

    Published in Antiviral research (01-11-2008)
    “…These studies were performed to determine the effect of AD-472, an attenuated human herpes simplex virus (HSV) type 2 or HSV-2 glycoprotein D (gD) when…”
    Get full text
    Journal Article
  14. 14

    Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins by Marciani, Dante J., Pathak, Ashish K., Reynolds, Robert C., Seitz, Lainne, May, Richard D.

    Published in International immunopharmacology (01-04-2001)
    “…Quillaja saponins are readily hydrolyzed under physiological conditions, yielding deacylated forms that are significantly less toxic than their precursors…”
    Get full text
    Journal Article
  15. 15

    Effectiveness of the quillaja saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systemic responses to recombinant HagB from Porphyromonas gingivalis by Zhang, Ping, Yang, Qiu-Bo, Marciani, Dante J, Martin, Michael, Clements, John D, Michalek, Suzanne M, Katz, Jannet

    Published in Vaccine (01-10-2003)
    “…The gram-negative, anaerobic bacterium Porphyromonas gingivalis, has been implicated in the etiology of adult periodontal disease. Among the potential…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Alzheimer’s disease: Toward the rational design of an effective vaccine by Marciani, Dante J.

    Published in Revista de neuro-psiquiatría (15-10-2015)
    “…The promising clinical results with the human monoclonal antibodies aducanumab and solanezumab targeting β-amyloidin Alzheimer’s disease treatment, confirm…”
    Get full text
    Journal Article
  18. 18

    Degradation of Quillaja saponaria Molina saponins: loss of the protective effects of a herpes simplex virus 1 subunit vaccine by Marciani, Dante J, Ptak, Roger G, Voss, Thomas G, Reynolds, Robert C, Pathak, Ashish K, Chamblin, Tyler L, Scholl, David R, May, Richard D

    Published in International immunopharmacology (01-11-2002)
    “…Quillaja saponins (Q. saponins) are readily hydrolyzed at neutral pH to yield degraded deacylated saponins (DS-saponins). Degradation of Q. saponins resulted…”
    Get full text
    Journal Article
  19. 19
  20. 20